Bespoke joint supplement manufacturing

Making joint supplements from glucosamine, collagen and PEA

Glucosamine and chondroitin, undenatured type II collagen, collagen peptides with vitamin C, palmitoylethanolamide (PEA) and standardised botanicals such as turmeric, boswellia and ginger go into the custom joint supplements we formulate and make for brands in our Leicester facility, where we work as a joint supplement manufacturer from formulation to finished product. We make capsules, tablets, powders, sachets and stick packs, liquids, shots and gummies, with glucosamine dosed on base content, undenatured type II collagen in milligrams and collagen peptides in grams. UK formulas stay below 1,178 mg a day of base glucosamine, and every batch comes with a certificate of analysis that reports glucosamine as base and as salt.

Joint supplements sit within our healthy ageing supplements category. In the EU, 22.0% of the population was aged 65 or over on 1 January 2025 (Eurostat, 2026).

We specify every active by source, form, grade and dose, and screen it against the GB register and the EU Union list.

Glucosamine

Glucosamine is an amino sugar, supplied as glucosamine hydrochloride or as glucosamine sulfate, which takes up moisture readily and is stabilised as a double salt with potassium or sodium chloride. Conventional glucosamine comes from crustacean shells, which brings crustacean allergen labelling. For non-shellfish products, as of October 2026, glucosamine hydrochloride and glucosamine sulfate from Aspergillus niger and a genetically modified E. coli K-12 strain can be used in food supplements in GB and the EU as authorised novel foods, at levels in line with normal use of glucosamine from shellfish.

Chondroitin sulfate

Chondroitin is a glycosaminoglycan extracted from bovine, porcine, chicken or fish cartilage. Source sets the sulfation pattern, molecular weight and certification route, so we specify all three. For non-animal products, chondroitin sulfate made by microbial fermentation and chemical sulfation can be used in adult food supplements in GB and the EU at up to 1,200 mg a day, excluding pregnant and lactating women, as an authorised novel food labelled "Chondroitin sulphate derived from microbial fermentation and sulphation".

Undenatured type II collagen

Collagen from chicken sternum cartilage, processed at low temperature to keep its native structure. It is dosed in milligrams: a 120-day trial in 55 healthy adults used 40 mg a day of the ingredient, supplying about 10 mg of native type II collagen (Lugo and colleagues, 2013). Heat changes it, so it suits capsules and cool-processed tablets rather than cooked gummies, and we specify native collagen content and its test method with the supplier.

Collagen peptides with vitamin C

Hydrolysed collagen from bovine, porcine, marine or chicken sources, dosed in grams. No joint claim is authorised for collagen hydrolysate in GB or the EU, so labels lean on vitamin C. See collagen supplement manufacturing.

PEA (palmitoylethanolamide)

PEA, a fatty acid amide the body makes itself, is a newer joint active with a small human evidence base. A 2018 risk assessment by the DTU National Food Institute for the Danish Veterinary and Food Administration calculated a safe intake of 5 mg per kg of body weight a day, about 350 mg for a 70 kg adult (DTU, 2018), and we set PEA doses with that reference in view.

Botanicals

Turmeric, boswellia and ginger are common choices, each standardised to marker compounds and checked against national plant lists. Turmeric needs extra care: some curcumin extracts are novel foods, and, as of October 2026, tetrahydrocurcuminoids can be used in EU adult food supplements at up to 140 mg a day, sourced only from the applicant until 11 July 2027, but not in GB, so every curcumin form is screened before use.

Glucosamine below 1,178 mg for UK supplements, by base content

Claims follow the register, not the research, so joint labels in GB and the EU rest on nutrients. The table sets out the position as of October 2026, from the GB register of permitted claims, the EU register and US law.

The UK threshold rules out 1,500 mg of glucosamine hydrochloride a day, which supplies about 1,246 mg of base, so we set UK formulas on base content from the first brief, in line with the MHRA's published position. In the EU, the Union list authorises non-shellfish glucosamine for food supplements and each member state classifies products case by case, so we confirm the classification in every target country before launch.

Botanicals carry national conditions too: turmeric supplements sold in Italy need a label warning set by the Italian Ministry of Health, and its guidelines list no physiological effects for turmeric. Botanical claims remain on hold in GB and the EU, as our supplement regulation watch tracks each quarter. We keep symptom and medicinal wording off labels and adverts in every market.

Base or salt weight: dosing glucosamine, curcumin and vitamin C

Dose by base content. Glucosamine doses are set on glucosamine base, not salt weight. From molecular weights, glucosamine hydrochloride is about 83% base, so 1,500 mg supplies about 1,246 mg of glucosamine, while the potassium chloride double salt of glucosamine sulfate is about 59% base, so 1,500 mg supplies about 888 mg.

Absorption. Curcumin is poorly absorbed alone, so formulas add piperine or use enhanced-bioavailability forms. Those forms raise exposure, so we set each curcumin dose for the form used, not for curcumin content alone, and record the form and the dose in the specification.

Stability and interactions. Glucosamine is a reducing amino sugar, so in powders and liquids it takes part in Maillard browning with proteins and amino acids, faster with heat and moisture; collagen and glucosamine powders need water activity control and stability data. Vitamin C oxidises in solution, faster with heat, oxygen and trace metals, so liquids carry an overage set from stability data. Labels advise anyone taking medicines to speak to their doctor or pharmacist before use.

Oval tablets under 22 mm, collagen sticks and joint shots

• Capsules and tablets carry glucosamine, chondroitin, undenatured type II collagen, PEA and botanical extracts. Gram doses usually need two or more units a day, so we keep tablets oval and within the 22 mm largest dimension that FDA's guidance on generic tablets recommends (FDA, 2022). Capsules are GMP certified; see capsule and tablet manufacturing.
• Powders, sachets and stick packs carry collagen peptides at gram doses with vitamin C, with or without glucosamine; see powder supplement manufacturing.
• Liquids and shots carry collagen, glucosamine and vitamin C for customers who would rather not swallow tablets, and are GMP certified; see liquid supplement manufacturing.
• Gummies suit vitamin C and modest collagen doses, are GMP certified and get an active assay on every batch as standard.
• Combination formulas pair joint actives with protein and vitamin D for active-ageing ranges; see muscle health supplement manufacturing.

Every format is made in our Leicester facility, which is ISO 9001, HACCP and GMP certified by BSI, and FDA registered.

Tablet size and unit count, set by a joint supplement manufacturer

Every formula runs through our development stages: brief, evidence review, formulation, bench samples, blind sensory panels, a pilot batch on production equipment, stability in the final pack, and scale-up. Each stage leaves a record you keep. Joint formulas carry gram doses, so development also settles the unit count, the tablet or capsule size and the serving customers take every day.

1. Brief and classification check. We agree markets and claims first, and check glucosamine base against the UK threshold, the novel food status of newer actives and national botanical lists.
2. Supplier approval and source documents. Every material comes from an approved supplier, with species, source and allergen status documented.
3. Dispensing and blending. Actives are weighed against the batch record; milligram actives such as undenatured type II collagen are pre-blended for uniformity, with heat kept low.
4. Forming and filling. Capsules are filled to a set weight, tablets compressed and coated, and powders and sticks filled by weight, under humidity control for hygroscopic salts.
5. Packing. Capsules and tablets go into high-barrier bottles with induction seals and a desiccant, or into blisters; powders into foil-laminate stick packs, pouches or tubs; liquids and shots into bottles.
6. Labels and release. Labels are verified on every batch as our critical control point, and quality control releases every batch against its specification; nothing is dispatched without its sign-off.

The critical steps are crustacean and fish allergen control under our allergen management plan, uniformity for milligram actives, moisture control, and the label check.

A specific method for each joint active, from chondroitin to type II

Every batch is tested by accredited partner laboratories (ISO/IEC 17025) as part of every order, to a programme set per product and market, as our testing and batch release page explains.

• Glucosamine by HPLC against pharmacopoeial methods, reported as glucosamine base as well as salt.
• Chondroitin by a method specific to chondroitin sulfate, such as enzymatic digestion with HPLC, because titration methods also count other sulfated polysaccharides.
• Undenatured type II collagen by an immunoassay for native collagen agreed with the supplier.
• Botanicals by HPTLC fingerprint for identity, as set out in the European Pharmacopoeia and the United States Pharmacopeia, and HPLC for marker compounds such as curcuminoids.
• Contaminants: lead, cadmium and mercury against the EU limits for food supplements of 3.0, 1.0 and 0.10 mg/kg, plus microbiology.
• Stability: accelerated and real-time studies on every new formula, tracking actives, browning, moisture and vitamin C.

Every batch comes with a certificate of analysis, with glucosamine reported as base and as salt, and a batch release confirmation; development adds the formula, the specification with its test methods, stability data and a claims review for each market. We keep three retained samples per batch for shelf life plus one year. Vegan, halal and kosher certification are arranged for your product. R&D is a paid stage that can be included with an order of the right size. Your formula is yours. Start your project.

References: Regulation (EU) No 432/2012 (2012); Regulation (EU) No 379/2012 (2012); MHRA, change in the classification of certain glucosamine products (2018); Food Standards Agency, register of authorised novel foods, glucosamine and chondroitin entries (2025); Commission Implementing Regulation (EU) 2022/961 (2022); Lugo and colleagues, undenatured type II collagen trial in healthy adults (2013); DTU National Food Institute, risk assessment of PEA in food supplements (2018).